Get the Daily Brief
Latest Biotech News
FDA Leadership Turmoil Marks Agency Shift
The U.S. Food and Drug Administration is experiencing significant leadership upheaval, highlighted by the announced retirement of Jacqueline Corrigan-Curay, acting head of the Center for Drug...
Illumina Expands Proteomics Business with SomaLogic Acquisition
Illumina has agreed to acquire SomaLogic from Standard BioTools in a deal worth up to $425 million, aiming to bolster its multiomics strategy and proteomics capabilities. This acquisition...
Novel Cancer Therapies Show Clinical Progress and Partnerships
Several innovative cancer therapies and strategic partnerships emerged as focal developments. Roche reported promising Phase 3 trial results combining bispecific and antibody-drug conjugate...
Breakthroughs in Diabetes and Obesity Treatments
Noteworthy advances in diabetes and obesity therapies include Amgen’s adjustment of dosing schedules for its obesity drug MariTide following Phase 2 data showing significant weight loss but high...
Chromosomal Instability Biomarkers Predict Chemotherapy Resistance
Researchers at the Spanish National Cancer Research Centre and collaborators developed genomic tests harnessing chromosomal instability (CIN) signatures to predict patient resistance to multiple...
Advances in Medical Imaging: Novel PET Tracers Enhance Cancer Detection
Innovations in molecular imaging have emerged with development of novel PET tracers enhancing cancer diagnosis. Shandong Cancer Hospital introduced a peptide-based tracer outperforming ^18F-FDG in...
Innovative AI Applications Accelerate Biotech and Healthcare Progress
Artificial intelligence continues to reshape biotech and healthcare domains. Michigan State University researchers combined nanomedicine and AI to detect rare cancer biomarkers, improving early...
New Insights into Neuroscience and Neurological Therapies
Notable neuroscience advances include detailed mapping of native calcium-permeable AMPA receptors critical to cerebellum function, providing therapeutic avenues to repair injury-induced...
Cidara’s CD-388 Flu Biologic Surges Ahead with Phase IIb Success
San Diego-based Cidara Therapeutics reported highly favorable results from its randomized, double-blind, placebo-controlled Phase IIb Navigate trial, testing the long-acting antiviral biologic...
Illumina Acquires SomaLogic to Strengthen Multiomics Strategy
Illumina announced its definitive agreement to acquire proteomics technology company SomaLogic from Standard BioTools for an upfront $350 million in cash plus up to $75 million in near-term...
FDA Leadership Shakeup: Acting CDER Head Jacqueline Corrigan-Curay to Retire
Amid ongoing leadership turmoil at the U.S. Food and Drug Administration, Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research (CDER), announced her upcoming...
Novel PET Tracers Enhance Cancer Detection and Immune Profiling
Researchers have made strides in molecular imaging with new positron emission tomography (PET) tracers targeting immune checkpoint proteins PD-L1 and glypican-3 (GPC3) in cancers. The...
Breakthroughs in Type 1 and Type 2 Diabetes Treatments
Vertex Pharmaceuticals’ cell therapy zimislecel showed promising Phase 1/2 results in type 1 diabetes, with most patients achieving insulin independence and controlled blood glucose one year...
Precision Oncology Advances with Genomic Chemotherapy Resistance Biomarkers
An international collaboration led by the Spanish National Cancer Research Centre and partners at Cambridge and Tailor Bio has developed a novel genomic test leveraging chromosomal instability...
AI and Robotics Transform Airway Management and Biomechanics Prediction
Medical technology innovations are advancing airway management with robotic intubation systems and AI-powered anatomical recognition, promising improvements in accuracy and patient safety during...
Innovations in Neuroscience: Brain Mapping and Epilepsy Management
Washington University researchers developed Cirrus, an AI-driven resting state fMRI software approved by the FDA, that accelerates neurosurgical brain mapping by producing detailed functional...
Cancer Therapy Advances: Bispecifics, Antibody-Drug Conjugates, and CAR-T Enhancements
Recent developments in oncology include a phase 3 trial where Roche’s combination of bispecific antibody Lunsumio and antibody-drug conjugate Polivy significantly improved progression-free...
Cidara's Flu Prevention Treatment Surges on Promising Trial Data
Cidara Therapeutics reported positive Phase 2b results for its long-acting antiviral biologic CD-388, designed to prevent seasonal influenza in healthy adults aged 18 to 64. The single-dose...
FDA Leadership Changes Stir Biopharma Industry Concerns
The FDA is undergoing significant leadership turnover with Jacqueline Corrigan-Curay, acting head of the Center for Drug Evaluation and Research (CDER), announcing her retirement in July. This...
Illumina Acquires SomaLogic to Expand Proteomics and Multiomics
Illumina has agreed to acquire SomaLogic from Standard BioTools for up to $425 million. The acquisition expands Illumina’s capabilities in proteomics and enhances its multiomics strategy by...